Skip to main content

ABBV vs BMY: Stock Comparison

AbbVie Inc. compared with Bristol-Myers Squibb Company: size, valuation, growth, margins, dividends and returns.

ABBV vs BMY at a Glance

As of Nov 6, 2026, AbbVie Inc. (ABBV) has a market capitalization of $515.91B versus $127.57B for Bristol-Myers Squibb Company (BMY). Both companies are classified in the Drug Manufacturers - General industry.

ABBV trades at 81.8x trailing and 47.8x forward earnings, compared with 13.8x trailing and 7.6x forward earnings for BMY as of Nov 6, 2026. Over the trailing twelve months, revenue grew 10.4% at ABBV and 4.2% at BMY, operating margins were 28.2% and 29.0%, and net profit margins 9.8% and 18.5%.

As of Nov 6, 2026, ABBV has a dividend yield of 2.43% and BMY 4.00%. Over the past year ABBV shares changed +24.95% versus +43.74% for BMY (price change, dividends excluded).

Key Figures Side by Side

ABBV and BMY key figures side by side
MetricABBVBMY
Market cap$515.91B$127.57B
P/E ratio (TTM)81.7613.80
Forward P/E47.797.56
Revenue growth (TTM, YoY)10.39%4.16%
Gross margin (TTM)71.48%69.24%
Operating margin (TTM)28.17%29.00%
Net profit margin (TTM)9.80%18.47%
Dividend yield2.43%4.00%
1-year price change+24.95%+43.74%
SectorHealthcareHealthcare
IndustryDrug Manufacturers - GeneralDrug Manufacturers - General

Source: Exchange price data and company financial statements. Data as of Nov 6, 2026. Data sources and methodology

Interactive ABBV vs BMY Comparison

Performance Comparison

No chart data available

Comparison Results

Marked values are the best in their row where higher or lower is clearly better.

Side-by-side comparison; best value per row is marked
Stock
ABBV logo
ABBV
BMY logo
BMY
Price$291.31$62.14
Market Cap$515.91B$127.57B
Revenue (TTM)$64.39B (best)$50.03B
Net Income (TTM)$6.31B$9.24B (best)
EPS (TTM)$3.56$4.51 (best)
P/E Ratio81.7613.80 (best)
Dividend Yield2.43%4.00% (best)

Frequently Asked Questions

Which is bigger, ABBV or BMY?

AbbVie Inc. (ABBV) is larger as of Nov 6, 2026, with a market capitalization of $515.91B against $127.57B for Bristol-Myers Squibb Company (BMY), about 4.0 times the size.

Which stock is cheaper, ABBV or BMY?

On trailing earnings BMY is cheaper as of Nov 6, 2026: it trades at 13.8x versus 81.8x for ABBV. On forward earnings ABBV trades at 47.8x and BMY at 7.6x. A lower multiple can also reflect slower expected growth.

Which pays a higher dividend, ABBV or BMY?

BMY pays more as of Nov 6, 2026: its dividend yield is 4.00% versus 2.43% for ABBV.

Which has performed better, ABBV or BMY?

BMY has done better over the past year to Nov 6, 2026: its shares changed +43.74% against +24.95% for ABBV. These are price changes and exclude dividends.

More Comparisons